本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BriaCell Therapeutics Corp.

3.77
+0.31008.96%
盤後3.780.0100+0.27%17:41 EDT
成交量:66.35萬
成交額:254.42萬
市值:3,279.82萬
市盈率:-0.39
高:4.10
開:3.61
低:3.55
收:3.46
52周最高:14.68
52周最低:2.60
股本:869.98萬
流通股本:785.96萬
量比:0.35
換手率:8.44%
股息:- -
股息率:- -
每股收益(TTM):-9.6592
每股收益(LYR):-62.1862
淨資產收益率:-175.25%
總資產收益率:-90.84%
市淨率:1.36
市盈率(LYR):-0.06

資料載入中...

2025/08/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/16

重要事件披露

Form 8-K - Current report
2025/07/15

SEC問詢函

Form CORRESP - Correspondence
2025/07/15

SEC問詢函

Form CORRESP - Correspondence
2025/07/15

SEC問詢函

Form CORRESP - Correspondence
2025/07/15

SEC問詢函

Form CORRESP - Correspondence
2025/07/12

SEC問詢函

Form CORRESP - Correspondence
2025/07/12

SEC問詢函

Form CORRESP - Correspondence
2025/07/11

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/07/10

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/09

SEC問詢函

Form CORRESP - Correspondence
2025/07/09

SEC問詢函

Form CORRESP - Correspondence
2025/07/08

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/07/08

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/22

SEC問詢函

Form CORRESP - Correspondence